Tateishi, Ryosuke
Seike, Masataka
Kudo, Masatoshi
Tamai, Hideyuki
Kawazoe, Seiji
Katsube, Takayuki
Ochiai, Toshimitsu
Fukuhara, Takahiro
Kano, Takeshi
Tanaka, Katsuaki
Kurokawa, Mineo
Yamamoto, Kazuhide
Osaki, Yukio
Izumi, Namiki
Imawari, Michio
Funding for this research was provided by:
Shionogi & Co., Ltd.
Article History
Received: 28 December 2017
Accepted: 31 July 2018
First Online: 13 August 2018
Compliance with ethical standards
:
: Ryosuke Tateishi received grants from Kyowa Hakko Kirin Co., Ltd. outside the submitted work. Masataka Seike received lecture fees from Shionogi & Co., Ltd. outside the submitted work. Outside the submitted work, Masatoshi Kudo received grants from Novartis and Kaken, and lecture and consultancy fees from Eisai. Hideyuki Tamai, Seiji Kawazoe, Katsuaki Tanaka, and Kazuhide Yamamoto have no conflicts of interest to declare. Takayuki Katsube, Toshimitsu Ochiai, Takahiro Fukuhara, and Takeshi Kano are employees of Shionogi & Co., Ltd., which funded this study. Mineo Kurokawa received consultancy fees from Shionogi & Co., Ltd. during the conduct of the study. Outside the submitted work, Mineo Kurokawa received grants from Kyowa Hakko Kirin, Bristol-Myers Squibb, and Astellas. Yukio Osaki received consultancy fees from Shionogi & Co., Ltd. during the conduct of the study. Outside the submitted work, Yukio Osaki received lecture fees from Shionogi & Co., Ltd. Namiki Izumi received consultancy fees from Shionogi & Co., Ltd. during the conduct of the study, and lecture fees from Shionogi & Co., Ltd., Gilead Science, AbbVie, Otsuka, Bayer, and MSD outside the submitted work. Michio Imawari received consultancy fees from Shionogi & Co., Ltd. during the conduct of the study.